SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-041753
Filing Date
2024-05-10
Accepted
2024-05-10 16:30:17
Documents
15
Period of Report
2024-05-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205775-8k_longeve.htm   iXBRL 8-K 32052
2 PRESS RELEASE ISSUED BY THE COMPANY ON MAY 10, 2024 ea020577501ex99-1_long.htm EX-99.1 25903
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9112
  Complete submission text file 0001213900-24-041753.txt   255794

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgvn-20240506.xsd EX-101.SCH 3021
5 XBRL LABEL FILE lgvn-20240506_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE lgvn-20240506_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0205775-8k_longeve_htm.xml XML 3794
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 24935394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)